BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2902227)

  • 1. Serotonergic properties of spiroxatrine enantiomers.
    Nikam SS; Martin AR; Nelson DL
    J Med Chem; 1988 Oct; 31(10):1965-8. PubMed ID: 2902227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
    Nelson DL; Monroe PJ; Lambert G; Yamamura HI
    Life Sci; 1987 Sep; 41(13):1567-76. PubMed ID: 2957559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
    Herrick-Davis K; Titeler M
    J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
    Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G
    Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spiroxatrine derivatives towards 5-HT
    Sorbi C; Tait A; Battisti UM; Brasili L
    Pharmacol Rep; 2020 Apr; 72(2):427-434. PubMed ID: 32002826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and postnatal ontogeny and characterization of dopaminergic D2, serotonergic S2, and spirodecanone binding sites in rat forebrain.
    Bruinink A; Lichtensteiger W; Schlumpf M
    J Neurochem; 1983 May; 40(5):1227-36. PubMed ID: 6834058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
    Ismaiel AM; Titeler M; Miller KJ; Smith TS; Glennon RA
    J Med Chem; 1990 Feb; 33(2):755-8. PubMed ID: 2299641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous 3H-rauwolscine binding sites in rat cortex: two alpha 2-adrenoceptor subtypes or an additional non-adrenergic interaction?
    Broadhurst AM; Alexander BS; Wood MD
    Life Sci; 1988; 43(1):83-92. PubMed ID: 2838714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
    Anderson IK; Martin GR; Ramage AG
    Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The alpha-antiadrenergic properties of spiroxatrine, a ligand of serotonergic 5-HT1A receptors].
    Terrón JA; Ibarra M; Ransanz V; Hong E; Villalón CM
    Arch Inst Cardiol Mex; 1993; 63(4):289-95. PubMed ID: 8105762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
    Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
    J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
    Comoy C; Marot C; Podona T; Baudin ML; Morin-Allory L; Guillaumet G; Pfeiffer B; Caignard DH; Renard P; Rettori MC; Adam G; Guardiola-Lemaitre B
    J Med Chem; 1996 Oct; 39(21):4285-98. PubMed ID: 8863806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.